TaiMed Biologics Inc. (TPEX:4147)

TaiMed Biologics Statistics

Total Valuation

TPEX:4147 has a market cap or net worth of TWD 13.15 billion. The enterprise value is 11.88 billion.

Market Cap	13.15B
Enterprise Value	11.88B

Important Dates

The next estimated earnings date is Monday, May 11, 2026.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:4147 has 273.20 million shares outstanding. The number of shares has increased by 2.55% in one year.

Current Share Class	273.20M
Shares Outstanding	273.20M
Shares Change (YoY)	+2.55%
Shares Change (QoQ)	+2.76%
Owned by Insiders (%)	1.65%
Owned by Institutions (%)	5.98%
Float	181.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.52
PB Ratio	3.41
P/TBV Ratio	3.85
P/FCF Ratio	78.08
P/OCF Ratio	68.82
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-70.82
EV / Sales	19.43
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	70.52

Financial Position

The company has a current ratio of 13.11, with a Debt / Equity ratio of 0.13.

Current Ratio	13.11
Quick Ratio	7.36
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	2.95
Interest Coverage	-18.17

Financial Efficiency

Return on equity (ROE) is -4.26% and return on invested capital (ROIC) is -2.73%.

Return on Equity (ROE)	-4.26%
Return on Assets (ROA)	-2.48%
Return on Invested Capital (ROIC)	-2.73%
Return on Capital Employed (ROCE)	-4.27%
Weighted Average Cost of Capital (WACC)	3.45%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.12
Inventory Turnover	0.29

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.05% in the last 52 weeks. The beta is -0.13, so TPEX:4147's price volatility has been lower than the market average.

Beta (5Y)	-0.13
52-Week Price Change	-50.05%
50-Day Moving Average	55.75
200-Day Moving Average	71.64
Relative Strength Index (RSI)	32.20
Average Volume (20 Days)	994,675

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4147 had revenue of TWD 611.35 million and -167.78 million in losses. Loss per share was -0.61.

Revenue	611.35M
Gross Profit	259.45M
Operating Income	-194.65M
Pretax Income	-167.78M
Net Income	-167.78M
EBITDA	-41.04M
EBIT	-194.65M
Loss Per Share	-0.61

Balance Sheet

The company has 1.77 billion in cash and 497.28 million in debt, with a net cash position of 1.27 billion or 4.66 per share.

Cash & Cash Equivalents	1.77B
Total Debt	497.28M
Net Cash	1.27B
Net Cash Per Share	4.66
Equity (Book Value)	3.86B
Book Value Per Share	13.74
Working Capital	3.07B

Cash Flow

In the last 12 months, operating cash flow was 191.14 million and capital expenditures -22.67 million, giving a free cash flow of 168.48 million.

Operating Cash Flow	191.14M
Capital Expenditures	-22.67M
Depreciation & Amortization	153.61M
Net Borrowing	-29.50M
Free Cash Flow	168.48M
FCF Per Share	0.62

Margins

Gross margin is 42.44%, with operating and profit margins of -31.84% and -27.44%.

Gross Margin	42.44%
Operating Margin	-31.84%
Pretax Margin	-27.44%
Profit Margin	-27.44%
EBITDA Margin	-6.71%
EBIT Margin	-31.84%
FCF Margin	27.56%

Dividends & Yields

TPEX:4147 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.55%
Shareholder Yield	-2.55%
Earnings Yield	-1.28%
FCF Yield	1.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:4147 has an Altman Z-Score of 14.25 and a Piotroski F-Score of 4.

Altman Z-Score	14.25
Piotroski F-Score	4